• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Commun Med (Lond) . Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia

tetano

Editor, Senior Moderator
Commun Med (Lond)


. 2023 Oct 20;3(1):151.
doi: 10.1038/s43856-023-00376-9. Humoral immune response to SARS-CoV-2 and endemic coronaviruses in urban and indigenous children in Colombia

Nathalie Verónica Fernández Villalobos[SUP] #[/SUP][SUP] 1 [/SUP], Patrick Marsall[SUP] #[/SUP][SUP] 2 [/SUP], Johanna Carolina Torres Páez[SUP] 1 [/SUP], Julia Strömpl[SUP] 3 [/SUP], Jens Gruber[SUP] 2 [/SUP], Martín Lotto Batista[SUP] 1 4 [/SUP], Daria Pohl[SUP] 3 [/SUP], Gustavo Concha[SUP] 5 [/SUP], Hagen Frickmann[SUP] 6 7 [/SUP], Fernando Pio de la Hoz Restrepo[SUP] 8 [/SUP], Nicole Schneiderhan-Marra[SUP] 2 [/SUP], Gérard Krause[SUP] 3 9 10 11 [/SUP], Alex Dulovic[SUP] 2 [/SUP], Monika Strengert[SUP] 12 13 [/SUP], Simone Kann[SUP] 14 [/SUP]



Affiliations
Abstract

Background: Although anti-SARS-CoV-2 humoral immune responses and epidemiology have been extensively studied, data gaps remain for certain populations such as indigenous people or children especially in low- and middle-income countries. To address this gap, we evaluated SARS-CoV-2 seroprevalence and humoral immunity towards the parental B.1 strain, local SARS-CoV-2 variants, and endemic coronaviruses in children from Colombia from March to April 2021.
Methods: We performed a cross-sectional seroprevalence study with 80 children from Bogotá and expanded our analysis by comparing results with an independent observational study of 82 children from the Wiwa community living in the north-eastern Colombian territories. Antibody IgG titers towards SARS-CoV-2 and the endemic coronaviruses as well as ACE2 binding inhibition as a proxy for neutralization towards several SARS-CoV-2 variants were analyzed using two multiplex-based immunoassays.
Results: While we find seroprevalence estimates of 21.3% in children from Bogotá, seroprevalence is higher with 34.1% in Wiwa children. We observe a robust induction of antibodies towards the surface-exposed spike protein, its S1-, S2- and receptor-binding-subdomains in all SARS-CoV-2 seropositive children. Only nucleocapsid-specific IgG is significantly lower in the indigenous participants. ACE2 binding inhibition is low for all SARS-CoV-2 variants examined. We observe a dominance of NL63 S1 IgG levels in urban and indigenous children which suggests an early exposure to this respiratory virus independent of living conditions and geographic location. SARS-CoV-2 seropositivity does not correlate with antibody levels towards any of the four endemic coronaviruses indicating the absence of cross-protective immunity.
Conclusions: Overall, antibody titers, but in particular ACE2 binding inhibition are low within Colombian samples, requiring further investigation to determine any potential clinical significance.


 
Back
Top Bottom